Lightlake Therapeutics Inc. Chief Executive Officer Letter to Shareholders

Lightlake Therapeutics Inc. Chief Executive Officer Letter to Shareholders
We recently completed a two-week joint clinical study with the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), for opioid overdose. We received the initial data from this study and it has shown that our … Read more on PR Newswire (press release)

Latest survey tells us how many of our teens actually smoke, drink, and take drugs
That's what the University of Michigan and the National Institute on Drug Abuse seek to learn in their annual surveys of 40,000 to 50,000 teens in grades 8, 10, and 12. The latest Monitoring The Future survey was released today. Lloyd Johnston, the … Read more on Michigan Radio

Update on the latest in sports:
The All-American won the Biletnikoff (bih-LIHT'-nih-kahf) Award as the nation's most outstanding wide receiver after a season filled with big plays. He had 120 catches for 1,670 yards and 13 touchdowns, including 31 catches for more than 20 yards … Read more on WWSB ABC 7